Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of inflammatory markers with the disease & mutation status in pancreatic cancer.

The Indian journal of medical research - 1 Jan 2022

Singh Nidhi, Gupta Surabhi, Rashid Sumaira, Saraya Anoop

Abstract excerpt

Background & objectives: Inflammation has been studied to be an important contributory factor to carcinogenesis through pro-inflammatory markers such as interleukin (IL)-6 and C-reactive protein (CRP). Furthermore, K-ras mutation is an important genetic alteration in the pathogenesis of pancreatic cancer. This study aimed to compare these inflammatory markers in pancreatic ductal adenocarcinoma (PDAC) with the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Interleukin-6

Share to Mutation

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35859428
DOI: 10.4103/ijmr.IJMR_2238_18
PMCID: PMC9552386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Association of inflammatory markers with the disease & mutation status in pancreatic cancer.PMID 35859428Read ↗

Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress ResistanceSemantic proximity Read ↗

Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis.Semantic proximity Read ↗

Exploiting inflammation for therapeutic gain in pancreatic cancer.Semantic proximity Read ↗

Inflammation and pancreatic cancer: disease promoter and new therapeutic target.Semantic proximity Read ↗

Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.Semantic proximity Read ↗

Growth Factors and Cytokines in Pancreatic CarcinogenesisSemantic proximity Read ↗

Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.Semantic proximity Read ↗

Association between microRNA polymorphisms and chronic pancreatitis.Semantic proximity Read ↗

Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer.Semantic proximity Read ↗

Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.